HARP Insider Trading

74.01% of Harpoon Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Harpoon Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Blackstone Inc.	815,000	$9.27M	0.0%	N/A	4.813%
2/14/2024	Commodore Capital LP	1,500,000	$17.06M	1.5%	N/A	8.859%
2/14/2024	New Leaf Venture Partners L.L.C.	1,859,168	$21.14M	17.0%	+489.0%	10.982%
2/9/2024	Franklin Resources Inc.	1,492,368	$16.97M	0.0%	+1,027.8%	8.815%
1/31/2024	abrdn plc	25,991	$0.30M	0.0%	N/A	0.154%
11/15/2023	Kennedy Capital Management LLC	52,987	$0.21M	0.0%	-90.0%	1.366%
11/14/2023	MPM Bioimpact LLC	319,670	$1.29M	0.3%	-90.0%	8.239%
11/13/2023	Acadian Asset Management LLC	7,670	$29K	0.0%	-90.0%	0.198%
8/8/2023	Sequoia Financial Advisors LLC	63,955	$45K	0.0%	-36.0%	0.199%
8/7/2023	Acadian Asset Management LLC	76,710	$53K	0.0%	-32.5%	0.239%
5/8/2023	Bailard Inc.	63,200	$47K	0.0%	N/A	0.168%
5/1/2023	CM Wealth Advisors LLC	50,354	$29K	0.0%	N/A	0.134%
4/25/2023	Sequoia Financial Advisors LLC	100,000	$74K	0.0%	+66.7%	0.267%
2/13/2023	Levin Capital Strategies L.P.	330,000	$0.24M	0.0%	N/A	0.997%
11/15/2022	Piper Sandler & CO.	580,815	$0.56M	0.5%	N/A	1.754%
11/14/2022	Ergoteles LLC	70,054	$68K	0.0%	-23.8%	0.212%
9/16/2022	Federated Hermes Inc.	132,791	$0.25M	0.0%	+45.0%	0.401%
8/12/2022	Franklin Resources Inc.	1,324,504	$2.53M	0.0%	-20.4%	4.003%
5/20/2022	International Biotechnology Trust PLC	151,445	$2.77M	0.6%	-29.6%	0.458%
5/13/2022	Tekla Capital Management LLC	259,910	$1.29M	0.0%	N/A	0.786%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	14,872	$74K	0.0%	-37.0%	0.045%
2/15/2022	Sender Co & Partners Inc.	14,252	$0.11M	0.1%	N/A	0.044%
2/15/2022	Kennedy Capital Management Inc.	129,766	$0.98M	0.0%	N/A	0.396%
2/14/2022	Point72 Asset Management L.P.	650,000	$4.91M	0.0%	N/A	1.985%
2/14/2022	GSA Capital Partners LLP	35,266	$0.27M	0.0%	+42.0%	0.108%
2/10/2022	Candriam Luxembourg S.C.A.	809,568	$6.11M	0.0%	+65.4%	2.472%
2/10/2022	Panagora Asset Management Inc.	85,059	$0.64M	0.0%	+113.0%	0.260%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	23,595	$0.18M	0.0%	+110.2%	0.072%
2/8/2022	Northern Trust Corp	191,251	$1.44M	0.0%	-3.4%	0.584%
1/28/2022	Allspring Global Investments Holdings LLC	4,621	$34K	0.0%	N/A	0.014%
11/16/2021	Schonfeld Strategic Advisors LLC	84,272	$0.67M	0.0%	+41.1%	0.258%
11/16/2021	Squarepoint Ops LLC	14,703	$0.12M	0.0%	N/A	0.045%
11/16/2021	Two Sigma Advisers LP	377,500	$2.98M	0.0%	N/A	1.155%
11/16/2021	Two Sigma Investments LP	406,470	$3.21M	0.0%	N/A	1.244%
11/16/2021	Laurion Capital Management LP	305,954	$2.42M	0.0%	-51.5%	0.936%
11/16/2021	Millennium Management LLC	602,752	$4.76M	0.0%	+994.7%	1.845%
11/15/2021	Cubist Systematic Strategies LLC	45,121	$0.36M	0.0%	+356.9%	0.138%
11/15/2021	Dynamic Technology Lab Private Ltd	23,602	$0.19M	0.0%	N/A	0.072%
11/15/2021	Franklin Resources Inc.	1,131,753	$8.94M	0.0%	-0.5%	3.464%
11/15/2021	GSA Capital Partners LLP	24,838	$0.20M	0.0%	+40.7%	0.076%
11/12/2021	Affinity Asset Advisors LLC	250,000	$1.98M	0.5%	+400.0%	0.765%
11/12/2021	Trexquant Investment LP	29,435	$0.23M	0.0%	N/A	0.090%
11/12/2021	Renaissance Technologies LLC	400,788	$3.17M	0.0%	N/A	1.227%
11/12/2021	Jump Financial LLC	31,200	$0.25M	0.0%	N/A	0.096%
11/12/2021	International Biotechnology Trust PLC	215,000	$1.70M	0.4%	N/A	0.658%
11/12/2021	Geode Capital Management LLC	380,213	$3M	0.0%	+8.0%	1.164%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	11,225	$89K	0.0%	N/A	0.034%
11/10/2021	Goldman Sachs Group Inc.	87,398	$0.69M	0.0%	-60.8%	0.268%
11/10/2021	Panagora Asset Management Inc.	39,929	$0.32M	0.0%	-49.5%	0.122%
11/10/2021	IndexIQ Advisors LLC	21,491	$0.17M	0.0%	+11.1%	0.066%
11/10/2021	Citigroup Inc.	3,817	$30K	0.0%	-96.4%	0.012%
11/9/2021	Barclays PLC	31,167	$0.25M	0.0%	-13.7%	0.095%
11/9/2021	BlackRock Inc.	1,733,182	$13.69M	0.0%	+1.2%	5.305%
11/8/2021	Summit Global Investments	10,800	$85K	0.0%	N/A	0.033%
11/8/2021	Los Angeles Capital Management LLC	55,476	$0.44M	0.0%	-8.1%	0.170%
11/4/2021	Deutsche Bank AG	11,329	$89K	0.0%	-37.4%	0.035%
11/2/2021	New York State Common Retirement Fund	5,809	$46K	0.0%	-66.5%	0.018%
10/19/2021	Assenagon Asset Management S.A.	94,242	$0.75M	0.0%	N/A	0.288%
9/3/2021	Parametric Portfolio Associates LLC	10,509	$0.15M	0.0%	N/A	0.032%
8/25/2021	Marshall Wace North America L.P.	228,128	$3.16M	0.0%	+2.5%	0.698%
8/18/2021	Ikarian Capital LLC	113,600	$1.58M	0.1%	-57.7%	0.348%
8/17/2021	Logos Global Management LP	800,000	$11.10M	0.9%	+166.7%	2.449%
8/17/2021	Boothbay Fund Management LLC	13,508	$0.19M	0.0%	-57.7%	0.041%
8/16/2021	Nantahala Capital Management LLC	443,247	$6.15M	0.2%	-2.1%	1.357%
8/16/2021	California State Teachers Retirement System	25,860	$0.36M	0.0%	+26.5%	0.079%
8/16/2021	Schonfeld Strategic Advisors LLC	59,724	$0.83M	0.0%	-3.2%	0.183%
8/16/2021	Maven Securities LTD	618,610	$8.46M	0.3%	+375.9%	1.894%
8/16/2021	Charles Schwab Investment Management Inc.	173,102	$2.40M	0.0%	+10.7%	0.530%
8/16/2021	State Street Corp	1,328,368	$18.42M	0.0%	+549.0%	4.066%
8/16/2021	Nuveen Asset Management LLC	117,867	$1.64M	0.0%	+21.4%	0.361%
8/16/2021	Federated Hermes Inc.	128,249	$1.78M	0.0%	+75,787.0%	0.393%
8/16/2021	Goldman Sachs Group Inc.	223,039	$3.09M	0.0%	+404.6%	0.683%
8/13/2021	VR Adviser LLC	512,005	$7.10M	0.9%	N/A	1.567%
8/13/2021	Northern Trust Corp	209,369	$2.90M	0.0%	+17.2%	0.641%
8/13/2021	Affinity Asset Advisors LLC	50,000	$0.69M	0.2%	+150.0%	0.153%
8/13/2021	Laurion Capital Management LP	630,571	$8.75M	0.0%	+45.5%	1.930%
8/13/2021	Franklin Resources Inc.	1,137,505	$15.78M	0.0%	+5.9%	3.482%
8/13/2021	Qube Research & Technologies Ltd	54,029	$0.75M	0.0%	N/A	0.165%
8/13/2021	Geode Capital Management LLC	351,962	$4.88M	0.0%	+19.2%	1.077%
8/13/2021	MPM Asset Management LLC	3,130,267	$43.42M	8.1%	-3.3%	9.581%
8/13/2021	Vanguard Group Inc.	1,255,845	$17.42M	0.0%	+5.7%	3.844%
8/13/2021	MPM Oncology Impact Management LP	3,196,707	$44.34M	7.3%	-18.0%	9.785%
8/13/2021	Bailard Inc.	118,878	$1.65M	0.1%	-9.1%	0.364%
8/13/2021	ProShare Advisors LLC	10,697	$0.15M	0.0%	N/A	0.033%
8/12/2021	XTX Topco Ltd	10,898	$0.15M	0.1%	N/A	0.033%
8/12/2021	Dimensional Fund Advisors LP	94,484	$1.31M	0.0%	+221.5%	0.289%
8/12/2021	JPMorgan Chase & Co.	228,316	$3.17M	0.0%	-4.9%	0.699%
8/12/2021	The Manufacturers Life Insurance Company	12,036	$0.17M	0.0%	N/A	0.037%
8/11/2021	Bank of New York Mellon Corp	46,389	$0.64M	0.0%	+14.2%	0.142%
8/11/2021	BlackRock Inc.	1,713,296	$23.77M	0.0%	+2.7%	5.244%
8/11/2021	Deutsche Bank AG	18,102	$0.25M	0.0%	+16.5%	0.055%
8/11/2021	Panagora Asset Management Inc.	79,079	$1.10M	0.0%	-6.7%	0.243%
8/10/2021	Virtus ETF Advisers LLC	14,488	$0.20M	0.1%	-31.8%	0.045%
8/10/2021	Citigroup Inc.	104,669	$1.45M	0.0%	+704.3%	0.322%
8/10/2021	Rafferty Asset Management LLC	59,549	$0.83M	0.0%	N/A	0.183%
8/5/2021	Rhumbline Advisers	14,560	$0.20M	0.0%	+40.8%	0.045%
8/5/2021	Los Angeles Capital Management LLC	60,336	$0.84M	0.0%	+152.8%	0.186%
8/5/2021	GSA Capital Partners LLP	17,659	$0.25M	0.0%	-27.1%	0.054%
8/4/2021	IndexIQ Advisors LLC	19,339	$0.27M	0.0%	-5.5%	0.059%
8/2/2021	New York State Common Retirement Fund	17,331	$0.24M	0.0%	+64.8%	0.053%

Data available starting January 2016

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candidate, including HPN328, which is in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; and HPN217 that is in Phase I clinical trials for the treatment of multiple myeloma. Its preclinical stage product is HPN601 for the treatment of multiple solid tumor indications. It has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate its proprietary TriTAC platform technology together with soluble T cell receptors. The company was incorporated in 2015 and is headquartered in South San Francisco, California. As of March 11, 2024, Harpoon Therapeutics, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.

Today's Range

Now: $23.01

$23.01

50 Day Range

MA: $22.89

$22.34

$23.01

52 Week Range

Now: $23.01

$3.11

$23.21

Volume

N/A

Average Volume

1,516,200 shs

Market Capitalization

$389.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Harpoon Therapeutics?: Harpoon Therapeutics' top insider investors include:
Merck & Co, Inc (Major Shareholder)
Ronald Hunt (Director)
Learn More about top insider investors at Harpoon Therapeutics.